SCHEMBL24854231

SCHEMBL24854231

Cc1ccc2[nH]ncc2c1C(C)(C)Cc1cc(C)c(C(C)C)c2c(Cl)n[nH]c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21733602 0.73 NOS1 (0.31) —
SCHEMBL26420404 0.72 — —
SCHEMBL26420406 0.69 CDK2 (0.32) —
SCHEMBL18408609 0.69 — —
SCHEMBL21938210 0.68 IDO1 (0.38) —
SCHEMBL20858119 0.68 TRPV1 (0.35) —
SCHEMBL24854355 0.67 JAK2 (0.31) —
SCHEMBL12110234 0.67 METAP2 (0.46) —
SCHEMBL24285781 0.67 IDO1 (0.34) —
SCHEMBL24854886 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002382-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUNDS Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-01-05 — — US disclosed
Send feedback